×
For best experience we recommend to activate Javascript in your browser.
DR3/LARD antibody
TNFRSF25
Reactivity: Human
FACS
Host: Mouse
Monoclonal
JD3
unconjugated
Product Details anti-DR3/LARD Antibody
(hide)
Target
See all DR3/LARD (TNFRSF25) Antibodies
DR3/LARD (TNFRSF25)
(Tumor Necrosis Factor Receptor Superfamily, Member 25 (TNFRSF25))
Reactivity
All reactivities for DR3/LARD antibodies
Human
Host
All hosts for DR3/LARD antibodies
Mouse
Clonality
All clonalities for DR3/LARD antibodies
Monoclonal
Conjugate
All conjugates for DR3/LARD antibodies
This DR3/LARD antibody is un-conjugated
Application
All applications for DR3/LARD antibodies
Flow Cytometry (FACS)
Purification
The antibody was purified by affinity chromatography.
Clone
JD3
Isotype
IgG1 kappa
Top Product
Discover our top product TNFRSF25 Primary Antibody
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Concentration
0.5 mg/mL
Buffer
Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C
Storage Comment
The antibody solution should be stored undiluted between 2°C and 8°C.
Target Details for DR3/LARD
(hide)
Target
DR3/LARD (TNFRSF25)
(Tumor Necrosis Factor Receptor Superfamily, Member 25 (TNFRSF25))
Alternative Name
DR3 (TNFRSF25 Products )
Background
DR3 is also known as TNFRSF25, Apo-3, WSL-1, TRAMP, LARD, DDR3, and TR3. It is a member of the TNF receptor family expressed at low level by monocytes and granulocytes. Interaction of DR3 with its ligand (TWEAK), activates the NF-κB pathway and induces apoptosis.
Pathways
Apoptosis
Recently viewed
(hide)